These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 5337474)

  • 1. [Current views on the pathogenesis of deficiency of the antihemophilic globulin (factor 8)].
    Uszyński L
    Pol Tyg Lek; 1966 Jun; 21(24):958-60. PubMed ID: 5337474
    [No Abstract]   [Full Text] [Related]  

  • 2. [Quantitative determination of antihemophilic globulin (Factor VIII)].
    Lisichkov T
    Vutr Boles; 1972; 11(4):62-7. PubMed ID: 4680004
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pseudohemophilia due to antihemophilic globulin inhibitor (factor VIII)].
    Procházka J; Podivínský R; Kouril F; Hadam I; Velemínský J
    Vnitr Lek; 1970 Nov; 16(11):1091-103. PubMed ID: 5488288
    [No Abstract]   [Full Text] [Related]  

  • 4. [Activation of antihemophilic globulin A (factor VIII). 1. Activation by ampholine].
    Liebe S; Thierbach B
    Z Gesamte Inn Med; 1982 Feb; 37(4):105-10. PubMed ID: 6805143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasma antihemophilic globulin concentrations in hemophiliacs and their relatives].
    Müftüoğlu AU; Ulutin O
    Tip Fak Mecm; 1965; 28(3):228-38. PubMed ID: 5882938
    [No Abstract]   [Full Text] [Related]  

  • 6. [Activation of the antihemophilic globulin A (factor VIII). 2. Effect of ampholine on the course of blood coagulation and the molecular conformation of factor VIII].
    Liebe S
    Z Gesamte Inn Med; 1982 Feb; 37(4):110-6. PubMed ID: 6805144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term follow-up of consumption of plasma, blood and antihemophilic globulin in patients with hemophilia].
    Pudlák P; Horák J
    Vnitr Lek; 1968 Jan; 15(1):1-8. PubMed ID: 5720983
    [No Abstract]   [Full Text] [Related]  

  • 8. Preparation and testing of antihemophilic globulin (Factor 8) sources for transfusion therapy in hemophilia. Description of a new sterile concentrate process for blood banks.
    Pool JG
    Scand J Clin Lab Invest; 1965; 17():Suppl 84:70-7. PubMed ID: 5862567
    [No Abstract]   [Full Text] [Related]  

  • 9. [The activity of antihemophilic globulin in blood donors].
    Novák J; Sejkorová J; Urbánková J
    Vnitr Lek; 1966 Jun; 12(6):580-6. PubMed ID: 5916566
    [No Abstract]   [Full Text] [Related]  

  • 10. [On 4 cases of hemophilia A with partial deficiency of antihemophilic globulin].
    DIGILIO G; BACCHETTA V; SAVIGNONI PG
    Arch Ital Pediatr Pueric; 1961 Dec; 21():473-82. PubMed ID: 13886365
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of erythrophosphatide in the determination of antihemophilic globulin activity].
    Rakitianskaia AA; Tsvirko DG; Gilevskiĭ EN
    Lab Delo; 1983; (6):22-4. PubMed ID: 6193315
    [No Abstract]   [Full Text] [Related]  

  • 12. Development and present status of concentrate therapy for hemophilia and von Willebrand's disease.
    Brinkhous KM
    Wien Klin Wochenschr; 1982 Oct; 94(19):509-14. PubMed ID: 6818773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preventive treatment with antihemophilic globulin concentrates of animal origin in 2 hemophilic patients undergoing surgery].
    d' Auteuil P; Sirois M
    Union Med Can; 1966 Jun; 95(6):695-700. PubMed ID: 5936513
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comments on the paper by H. Köstering, H.-K. Wellmer, K. Fuchs, and P. Völker: "Gastric resection in severe hemophilia A during substitution with porcine antihemophilic globulin". Der Chirurg 41, 266 (1970)].
    Wedell J
    Chirurg; 1972 Feb; 43(2):85-7. PubMed ID: 5063670
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the purification of antihemophilic factor (factor VIII). II. Separation of partially purified antihemophilic factor by gel filtration of plasma.
    Ratnoff OD; Kass L; Lang PD
    J Clin Invest; 1969 May; 48(5):957-62. PubMed ID: 5780204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current status of the preparation and use of antihemophilic fractions in France. (Their use in surgery in hemophilia)].
    Ménaché D; Josso F; Steinbuch M; Soulier JP
    Transfusion (Paris); 1966; 9(3):237-44. PubMed ID: 5969559
    [No Abstract]   [Full Text] [Related]  

  • 17. Rationale and indications for continuous infusion of antihemophilic factor (factor VIII).
    Goldsmith JC
    Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S3-6. PubMed ID: 8735789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modification of J.G. Pool's technic for the production of cryoprecipitates with highly concentrated antihemophilic globulin (factor 8) content. I].
    Wegner H; Bergmann A
    Z Gesamte Inn Med; 1967 Jul; 22(13):389-92. PubMed ID: 5592690
    [No Abstract]   [Full Text] [Related]  

  • 19. ANTIHEMOPHILIC GLOBULIN DEFICIENCY IN A CHROMOSOMAL FEMALE.
    LUSHERJMSTAUB RT; BELOTE JH
    Am J Dis Child; 1964 Sep; 108():309-14. PubMed ID: 14168070
    [No Abstract]   [Full Text] [Related]  

  • 20. [Female hemophilia and its management with human antihemophilic globulin].
    BLOMBACK BIRGER ; BLOMBACK MARGARETA ; NILSSON IM; SVENNERUD S
    Nord Med; 1956 Nov; 56(46):1654-6. PubMed ID: 13388148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.